Stay updated on Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.

Latest updates to the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check21 days agoChange DetectedA notice about NIH website updates and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record.SummaryDifference0.4%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check55 days agoChange DetectedA new Revision: v3.7.0 entry was added to the Study Record Versions and the previous Revision: v3.6.6 entry was removed, updating the version history presented on the page.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry v3.6.6 was added to the record history and the prior entry v3.6.5 was removed from the visible history. This updates the study’s version history without modifying study data or page functionality.SummaryDifference0.1%

Stay in the know with updates to Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.